Recent News for HTBX - Heat Biologics, Inc.

Date Title
Oct 4 Heat Biologics files to offer shares, warrants
Oct 2 What Kind Of Shareholders Own Heat Biologics, Inc. (NASDAQ:HTBX)?
Aug 27 Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Collapsed 99%
Aug 26 HTBX: HS-130 Ready To Go
Aug 24 10 Biopharmaceutical Companies Trying To Cure Cancer
Aug 14 Heat Biologics EPS in-line, misses on revenue
Aug 14 Heat Biologics Reports Second Quarter 2019 Results and Provides Corporate Update
Aug 12 Heat Biologics on go with early-stage study of cancer doublet therapy; shares up 12% premarket
Aug 12 Heat Biologics Announces FDA Clearance of IND Application to Begin Phase 1 Trial of HS-130 in Combination with Heat’s HS-110
Aug 7 Heat Biologics CEO and Lead Director to Participate in German Investor Forums
Jul 31 28 Healthcare Stocks Moving In Tuesday's After-Market Session
Jul 30 Benzinga's Top Upgrades, Downgrades For July 30, 2019
Jul 30 Two shops soften view on Pfizer in premarket analyst action
Jul 10 What You Must Know About Heat Biologics, Inc.'s (NASDAQ:HTBX) Beta Value
Jul 10 The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV
Jul 9 Heat Biologics Completes Enrollment in Phase 2 Non-Small Cell Lung Cancer Trial
Jul 9 The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering
Jun 12 HTBX: INDs To Be Filed Soon
Jun 3 Heat Biologics Announces Promising Interim Phase 2 Lung Cancer Data Suggesting that HS-110 Plus Nivolumab May Restore Clinical Benefit After Checkpoint Inhibitor Treatment Failure
May 24 The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice
May 23 Is Heat Biologics, Inc.'s (NASDAQ:HTBX) CEO Overpaid Relative To Its Peers?
May 20 Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
May 15 Heat Biologics beats by $0.01
May 15 Heat Biologics Reports First Quarter 2019 Results and Provides Corporate Update
May 14 The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings
Back to the Main HTBX Page...